Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

European Journal of Clinical Investigation

Volumn 42, Issue 12, 2012, Pages 1302-1308

  Gallego, Pilar ^a   Roldán, Vanessa ^a   Marín, Francisco ^b   Jover, Eva ^b   Manzano Fernández, Sergio ^b   Valdés, Mariano ^b   Vicente, Vicente ^a   Lip, Gregory Y H ^c  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Ankle brachial index; Atrial fibrillation; CHADS2 risk scale

Indexed keywords

AGE; AGED; ALCOHOL CONSUMPTION; ANKLE BRACHIAL INDEX; ANTICOAGULATED ATRIAL FIBRILLATION; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

AGED; ANKLE BRACHIAL INDEX; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84869871103     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12004     Document Type: Article

References (32)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82(suppl):2N-9N.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silberhatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
3. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64.
4. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67.
5. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
6. 2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis. Thromb Haemost 2011;106:528-38.
7. Karthikeyan G, Eikelboom JW. The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe? Thromb Haemost 2010;104:45-8.
8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
9. Frost L, Engholm G, Johnsen S, Møller H, Husted S. Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 2000;108:36-40.
10. Rasmussen LH, Larsen TB, Due KM, Tjønneland A, Overvad K, Lip GY. Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study. J Thromb Haemost 2011;9:1301-7.
11. Depta JP, Bhatt DL. Atherothrombosis and atrial fibrillation: important and often overlapping clinical syndromes. Thromb Haemost 2010;104:657-63.
12. Hirsch AT, Criqui MH, Treta-Jacobson D, Regensteiner JG, Creager MA, Olin JW. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
13. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005;25:1463-9.
14. Diehm C, Allenberg JR, Pittrow D et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053-61.
15. Ankle Brachial Index Collaboration; Fowkes FG, Murria GD, Butcher I et al. Ankle brachial index combined with Framingham Risk Store to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.
16. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey. Chest 2010;138:1093-100.
17. Anastas ZM, Jimerson E, Garolis S. Comparison of noninvasive blood pressure measurements in patients with atrial fibrillation. J Cardiovasc Nurs 2008;23:519-24.
18. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3:692-4.
19. Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011;57:173-80.
20. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-96.
21. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80years. J Am Coll Cardiol 2009;54:999-1002.
22. Heald CL, Fowkes FGR, Murray GD, Price JF; on behalf of the Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006;189:61-9.
23. Wattanakit K, Folsom AR, Duprez DA, Weatherley BD, Hirsch AT. Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2007;190:459-64.
24. Dhangana R, Murphy TP, Coll JR, Ahn SH, Zafar AM, Qadeer FF et al. Prevalence of abnormal ankle-brachial index among individuals with low or intermediate Framingham Risk Scores. J Vasc Interv Radiol 2011;22:1077-82.
25. Ramos R, Quesada M, Solanas P et al. REGICOR Investigators Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009;38:305-11.
26. Goto S, Bhatt DL, Röther J et al. REACH Registry Investigators Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855-63.
27. Olesen JB, Lip GY, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124.
28. McDermott MM, Liu K, Criqui MH et al. Ankle brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2005;162:33-41.
29. Fowkes FG, Housley E, Riemersma RA et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
30. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990;82:1925-31.
31. García AD, Lopes RD, Hylek EM. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Thromb Haemost 2010;104:1099-105.
32. Banerjee A, Lane DA, Torp-Pedersen C, Lip GYH. Net clinical benefit fo new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost 2012;107:584-9.